|
RSRC1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.84008364101373E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.43038963690879E-12 |
| Normal-vs-Stage2 |
9.50859999999665E-05 |
| Normal-vs-Stage3 |
1.78890235957851E-11 |
| Normal-vs-Stage4 |
1.35050004512749E-09 |
| Stage1-vs-Stage2 |
2.966000E-01 |
| Stage1-vs-Stage3 |
2.018200E-01 |
| Stage1-vs-Stage4 |
1.888750E-01 |
| Stage2-vs-Stage3 |
7.923900E-02 |
| Stage2-vs-Stage4 |
7.247900E-02 |
| Stage3-vs-Stage4 |
7.529000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.92859095149834E-14 |
| Normal-vs-AfricanAmerican |
5.598400E-02 |
| Normal-vs-Asian |
2.73689999552573E-08 |
| Caucasian-vs-AfricanAmerican |
3.681300E-03 |
| Caucasian-vs-Asian |
7.469600E-01 |
| AfricanAmerican-vs-Asian |
1.085730E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.94897439800934E-12 |
| Normal-vs-Female |
1.12739817481611E-11 |
| Male-vs-Female |
1.244980E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.20020027039436E-10 |
| Normal-vs-Age(41-60Yrs) |
4.47930581515266E-12 |
| Normal-vs-Age(61-80Yrs) |
9.6712999830828E-09 |
| Normal-vs-Age(81-100Yrs) |
3.441500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.038800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.844600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.371200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.802600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.944600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.264000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.418300E-03 |
| Classical-VS-Follicular |
2.338800E-01 |
| Classical-VS-Other |
3.477400E-01 |
| Classical-VS-Normal |
1.43779987915593E-10 |
| Tall-VS-Follicular |
1.780970E-01 |
| Tall-VS-Other |
9.006800E-01 |
| Tall-VS-Normal |
8.40959968329003E-10 |
| Follicular-VS-Other |
6.244600E-01 |
| Follicular-VS-Normal |
9.7211999561253E-09 |
| Other-VS-Normal |
2.899800E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.82940362647832E-11 |
| Normal-vs-N1 |
2.50730003426014E-09 |
| N0-vs-N1 |
2.740400E-01 |
|
|
